| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CTSO | Common Stock | Purchase | $15,298 | +5,000 | +15% | $3.06 | 38,700 | 10 May 2023 | See Footnote | F1 |
| transaction | CTSO | Common Stock | Purchase | $6,250 | +2,000 | +5.2% | $3.12 | 40,700 | 10 May 2023 | See Footnote | F1 |
| transaction | CTSO | Common Stock | Purchase | $9,510 | +3,000 | +7.4% | $3.17 | 43,700 | 10 May 2023 | See Footnote | F1 |
| holding | CTSO | Common Stock | 397,347 | 10 May 2023 | Direct | F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | These shares are held by the Reporting Person's husband in a 401(k) account. The Reporting Person may be deemed the beneficial owner of such shares. |
| F2 | Includes: (i) the following RSUs that will be settled into Common Stock upon a "Change In Control" of CytoSorbents Corporation (the "Company"), as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 8,800 RSUs granted on March 15, 2018, (b) 15,700 RSUs granted on February 24, 2017, (c) 47,000 RSUs granted on June 7, 2016 and (d) 110,000 RSUs granted on April 8, 2015; |
| F3 | (continued from footnote 2) (ii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date), and will be settled into common stock of the Company upon vesting: 37,000 RSUs granted on August 10, 2022; and |
| F4 | (continued from footnote 3) (iii) 178,847 shares of Common Stock owned by the Reporting Person. |